drugset / Trial / NCT00953641

Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy

NCT00953641

Phase 3 Withdrawn University of Saskatchewan
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether using Misoprostol vaginally before an office endometrial biopsy is performed, will make it easier, more successful and less painful to do the procedure. The investigators' hypothesis is that vaginal Misoprostol 12 hours prior to endometrial biopsy will increase the ease of performing office endometrial biopsy by reducing the need to use a tenaculum or a cervical dilator to achieve passage of a biopsy pipelle.

Timeline

Start
2011-09
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 400 ug Other